{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:19:03Z","timestamp":1779243543332,"version":"3.51.4"},"reference-count":44,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2016,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Developing countries are burdened with\n            <jats:named-content content-type=\"genus-species\">Shigella<\/jats:named-content>\n            diarrhea. Understanding mucosal immune responses associated with natural\n            <jats:named-content content-type=\"genus-species\">Shigella<\/jats:named-content>\n            infection is important to identify potential correlates of protection and, as such, to design effective vaccines. We performed a comparative analysis of circulating mucosal plasmablasts producing specific antibodies against highly conserved invasive plasmid antigens (IpaC, IpaD20, and IpaD120) and two recently identified surface protein antigens,\n            <jats:underline>p<\/jats:underline>\n            an-\n            <jats:underline>\n              <jats:italic>S<\/jats:italic>\n            <\/jats:underline>\n            <jats:italic>higella<\/jats:italic>\n            <jats:underline>s<\/jats:underline>\n            urface\n            <jats:underline>p<\/jats:underline>\n            rotein antigen 1 (PSSP1) and PSSP2, common to all virulent\n            <jats:named-content content-type=\"genus-species\">Shigella<\/jats:named-content>\n            strains. We examined blood and stool specimens from 37 diarrheal patients admitted to the Infectious Diseases &amp; Beliaghata General Hospital, Kolkata, India. The etiological agent of diarrhea was investigated in stool specimens by microbiological methods and real-time PCR. Gut-homing (\u03b1\n            <jats:sub>4<\/jats:sub>\n            \u03b2\n            <jats:sub>7<\/jats:sub>\n            <jats:sup>+<\/jats:sup>\n            ) antibody-secreting cells (ASCs) were isolated from patient blood by means of combined magnetic cell sorting and two-color enzyme-linked immunosorbent spot (ELISPOT) assay. Overall, 57% (21 of 37) and 65% (24 of 37) of the patients were positive for\n            <jats:named-content content-type=\"genus-species\">Shigella<\/jats:named-content>\n            infection by microbiological and real-time PCR assays, respectively. The frequency of \u03b1\n            <jats:sub>4<\/jats:sub>\n            \u03b2\n            <jats:sub>7<\/jats:sub>\n            <jats:sup>+<\/jats:sup>\n            IgG ASC responders against Ipas was higher than that observed against PSSP1 or PSSP2, regardless of the\n            <jats:named-content content-type=\"genus-species\">Shigella<\/jats:named-content>\n            serotype isolated from these patients. Thus, \u03b1\n            <jats:sub>4<\/jats:sub>\n            \u03b2\n            <jats:sub>7<\/jats:sub>\n            <jats:sup>+<\/jats:sup>\n            ASC responses to Ipas may be considered an indirect marker of\n            <jats:named-content content-type=\"genus-species\">Shigella<\/jats:named-content>\n            infection. The apparent weakness of ASC responses to PSSP1 is consistent with the lack of cross-protection induced by natural\n            <jats:named-content content-type=\"genus-species\">Shigella<\/jats:named-content>\n            infection. The finding that ASC responses to IpaD develop in patients with recent-onset shigellosis indicates that such responses may not be protective or may wane too rapidly and\/or be of insufficient magnitude.\n          <\/jats:p>","DOI":"10.1128\/cvi.00205-16","type":"journal-article","created":{"date-parts":[[2016,5,19]],"date-time":"2016-05-19T02:53:20Z","timestamp":1463626400000},"page":"610-617","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":6,"title":["Circulating Gut-Homing (\u03b1\n            <sub>4<\/sub>\n            \u03b2\n            <sub>7<\/sub>\n            <sup>+<\/sup>\n            ) Plasmablast Responses against Shigella Surface Protein Antigens among Hospitalized Patients with Diarrhea"],"prefix":"10.1128","volume":"23","author":[{"given":"Anuradha","family":"Sinha","sequence":"first","affiliation":[{"name":"National Institute of Cholera and Enteric Diseases, Kolkata, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayan","family":"Dey","sequence":"additional","affiliation":[{"name":"International Vaccine Institute, Seoul, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulietta","family":"Saletti","sequence":"additional","affiliation":[{"name":"International Vaccine Institute, Seoul, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradip","family":"Samanta","sequence":"additional","affiliation":[{"name":"National Institute of Cholera and Enteric Diseases, Kolkata, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Partha Sarathi","family":"Chakraborty","sequence":"additional","affiliation":[{"name":"National Institute of Cholera and Enteric Diseases, Kolkata, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. K.","family":"Bhattacharya","sequence":"additional","affiliation":[{"name":"National Institute of Cholera and Enteric Diseases, Kolkata, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santanu","family":"Ghosh","sequence":"additional","affiliation":[{"name":"National Institute of Cholera and Enteric Diseases, Kolkata, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Ramamurthy","sequence":"additional","affiliation":[{"name":"National Institute of Cholera and Enteric Diseases, Kolkata, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Ouk","family":"Kim","sequence":"additional","affiliation":[{"name":"International Vaccine Institute, Seoul, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Seung","family":"Yang","sequence":"additional","affiliation":[{"name":"International Vaccine Institute, Seoul, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Wook","family":"Kim","sequence":"additional","affiliation":[{"name":"International Vaccine Institute, Seoul, South Korea"},{"name":"College of Pharmacy, Hanyang University, Ansan, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecil","family":"Czerkinsky","sequence":"additional","affiliation":[{"name":"International Vaccine Institute, Seoul, South Korea"},{"name":"IPMC Nice-Sophia Antipolis, Nice, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranjan K.","family":"Nandy","sequence":"additional","affiliation":[{"name":"National Institute of Cholera and Enteric Diseases, Kolkata, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60844-2"},{"key":"e_1_3_3_3_2","first-page":"651","article-title":"Global burden of Shigella infections: implications for vaccine development and implementation of control strategies","volume":"77","author":"Kotloff KL","year":"1999","unstructured":"Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD, Swerdlow DL, Sansonetti PJ, Adak GK, Levine MM. 1999. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ 77:651\u2013666.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_3_4_2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1017\/S0950268807009351","article-title":"Part II. Analysis of data gaps pertaining to Shigella infections in low and medium human development index countries, 1984\u20132005","volume":"136","author":"Ram PK","year":"2008","unstructured":"Ram PK, Crump JA, Gupta SK, Miller MA, Mintz ED. 2008. Part II. Analysis of data gaps pertaining to Shigella infections in low and medium human development index countries, 1984\u20132005. Epidemiol Infect 136:577\u2013603.","journal-title":"Epidemiol Infect"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03746.x"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2010.06.037"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2014\/8434.4511"},{"key":"e_1_3_3_8_2","volume-title":"Bioterrorism agents\/diseases","author":"Centers for Disease Control and Prevention","year":"2013","unstructured":"Centers for Disease Control and Prevention. 2013. Bioterrorism agents\/diseases. CDC, Atlanta, GA. http:\/\/emergency.cdc.gov\/agent\/agentlist.asp#s."},{"key":"e_1_3_3_9_2","first-page":"51","article-title":"Future needs and directions for Shigella vaccines","volume":"81","author":"WHO","year":"2006","unstructured":"WHO. 2006. Future needs and directions for Shigella vaccines. Wkly Epidemiol Rec 81:51\u201358.","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.12"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0900891106"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.10.081"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2011.02.003"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8612994"},{"key":"e_1_3_3_15_2","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1172\/JCI119286","article-title":"Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses","volume":"99","author":"Quiding-J\u00e4rbrink M","year":"1997","unstructured":"Quiding-J\u00e4rbrink M, Nordstr\u00f6m I, Granstr\u00f6m G, Kilander A, Jertborn M, Butcher EC, Lazarovits AI, Holmgren J, Czerkinsky C. 1997. Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses. J Clin Invest 99:1281\u20131286.","journal-title":"J Clin Invest"},{"key":"e_1_3_3_16_2","doi-asserted-by":"crossref","first-page":"279206","DOI":"10.1155\/2012\/279206","article-title":"Persistence of diarrheal pathogens is associated with continued recruitment of plasmablasts in the circulation","volume":"2012","author":"Kantele A","year":"2012","unstructured":"Kantele A. 2012. Persistence of diarrheal pathogens is associated with continued recruitment of plasmablasts in the circulation. Clin Dev Immunol 2012:279206.","journal-title":"Clin Dev Immunol"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2013.058"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(90)90088-4"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.8.4808-4814.2003"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.07.022"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2010.00970.x"},{"key":"e_1_3_3_22_2","first-page":"73","volume-title":"Current topics in infectious diseases","author":"Dupont HL","year":"1980","unstructured":"Dupont HL, Larry KP. 1980. Infections of the gastrointestinal tract, p 73\u201374. In Current topics in infectious diseases. Plenum Medical Book Company, New York, NY."},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.5.2054-2061.1995"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.30.8.2165-2168.1992"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.9.5230-5234.2001"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.07.014"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.59.7.2341-2350.1991"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-2494(97)85227-3"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0966-842X(96)10039-1"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/cdli.3.2.242-245.1996"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.53.1.57-63.1986"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.31.2.454-457.1993"},{"key":"e_1_3_3_33_2","first-page":"110","article-title":"Immunogenicity of a new recombinant IpaC from Shigella dysenteriae type I in guinea pig as a vaccine candidate","volume":"10","author":"Malaei F","year":"2013","unstructured":"Malaei F, Hesaraki M, Saadati M, Ahdi AM, Sadraeian M, Honari H, Nazarian S. 2013. Immunogenicity of a new recombinant IpaC from Shigella dysenteriae type I in guinea pig as a vaccine candidate. Iran J Immunol 10:110\u2013117.","journal-title":"Iran J Immunol"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.04.012"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00859-13"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00661-14"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-1759(97)00030-6"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1186\/1757-4749-2-4"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.1999.01356.x"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.5.2457-2463.2000"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830250203"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146010"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(90)90094-3"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.04.045"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.2174\/156652409789105525"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00205-16","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00205-16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:51:51Z","timestamp":1627591911000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00205-16"}},"subtitle":[],"editor":[{"given":"M. F.","family":"Pasetti","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.1128\/CVI.00205-16"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00205-16","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"2016-04-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-05-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-07-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}